BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 27/01/2003

FDA Clears Chymopapain 10,000 Units/Vial Injection for Approval

The FDA has determined that chymopapain 10,000 units/vial injection was not withdrawn from sale due to safety or effectiveness concerns, paving the way for the approval of abbreviated new drug applications for this medication.

Source: Federal Register — Food and Drug AdministrationOpen original release →